https://www.selleckchem.com/pr....oducts/BIX-02189.htm
001). The adjusted mean %TBWL at 1year with classes I, -II, and -III obesity was 16.5%, 18.2%, and 20.5%, respectively. The overall complication rate and the hospital stay was identical in the three groups. ESG induced significant weight loss in all classes of obesity. In class III obesity, the weight loss achieved was significantly higher at 1year. In patients declining or unsuitable for surgery, ESG could be considered as an alternative treatment option. ESG induced significant weight loss in all classes of obesity. In class III obe